Clinical Trial Update: A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity [NA]

View source ↗

Summary

This completed trial compared oxybutynin and botulinum toxin for neurogenic detrusor overactivity in individuals with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Spinal Cord Injury

Drugs mentioned

• Botulinum toxin (botulinum toxin)
• oxybutynin (oxybutynin)

Snippet

Sponsor: Centro de Reabilitação e Readaptação Dr. Henrique Santillo | Conditions: Spinal Cord Injury | NA | Status: COMPLETED